Jason X. Cheng to Disease-Free Survival
This is a "connection" page, showing publications Jason X. Cheng has written about Disease-Free Survival.
Connection Strength
0.397
-
Improved prognosis with induction chemotherapy in pathological complete responders after trimodality treatment for esophageal squamous cell carcinoma: Hypothesis generating for adjuvant treatment. Eur J Surg Oncol. 2019 Aug; 45(8):1498-1504.
Score: 0.135
-
Differences in toxicity and outcome associated with circadian variations between patients undergoing daytime and evening radiotherapy for prostate adenocarcinoma. Chronobiol Int. 2016; 33(2):210-9.
Score: 0.108
-
Improved local control by surgery and paclitaxel-based chemoradiation for esophageal squamous cell carcinoma: results of a retrospective non-randomized study. J Surg Oncol. 2008 Jul 01; 98(1):34-41.
Score: 0.064
-
Should adjuvant radiotherapy to the supraclavicular fossa be routinely given in patients with breast conservative treatment? J Surg Oncol. 2007 Aug 01; 96(2):144-50.
Score: 0.060
-
Do We Need to Add Postoperative Radiotherapy in Patients Undergoing Trimodality Therapy for Esophageal Squamous Cell Carcinoma with Positive Lymph Nodes Disease? Dig Surg. 2018; 35(2):104-110.
Score: 0.030